Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.39 |
| ▸ | TRPM5 | Q9NZQ8 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | SYK | P43405 | 3/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.35 |
| ▸ | FEN1 | P39748 | 1/20 | 0.35 |
| ▸ | GRK2 | P25098 | 1/20 | 0.35 |
| ▸ | USP1 | O94782 | 1/20 | 0.35 |
| ▸ | WDR48 | Q8TAF3 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21614677 | 0.82 | CYP2C19 (0.60) | CYP2C19CYP3A4CYP2C9HDAC6CYP1A2 | |
| SCHEMBL21611982 | 0.81 | CYP2C19 (0.54) | CYP2C19CYP3A4CYP2C9CYP1A2GRK2 | |
| SCHEMBL21614661 | 0.80 | CYP2C19 (0.57) | CYP2C19CYP3A4CYP2C9HDAC6CYP1A2 | |
| SCHEMBL21614660 | 0.80 | CYP2C19 (0.63) | CYP2C19CYP3A4CYP2C9HDAC6CYP1A2 | |
| SCHEMBL21611979 | 0.78 | CYP2C19 (0.57) | CYP2C19CYP3A4CYP2C9HDAC6SYK | |
| SCHEMBL21612013 | 0.77 | CYP2C19 (0.61) | CYP2C19CYP3A4CYP2C9CYP1A2GRK2 | |
| SCHEMBL21612052 | 0.76 | CYP2C19 (0.58) | CYP2C19CYP3A4CYP2C9LOXL2GRK2 | |
| SCHEMBL21612024 | 0.76 | CYP2C19 (0.55) | CYP2C19CYP3A4CYP2C9CYP1A2F2 | |
| SCHEMBL21611952 | 0.76 | CYP3A4 (0.55) | CYP2C19CYP3A4CYP2C9CYP1A2GRK2 | |
| SCHEMBL21612043 | 0.74 | CYP2C19 (0.56) | CYP2C19CYP3A4CYP2C9HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210353606-A1 | PqsR INVERSE AGONISTS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2021-11-18 | — | — | US | disclosed |
| WO-2020007938-A1 | PqsR INVERSE AGONISTS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2020-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210353606-A1 | PqsR INVERSE AGONISTS | QRFPR, P2RY11, QARS1 | CYP2C19 1824/4885CYP3A4 3080/4885CYP2C9 2997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.